Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-12 Purchase | 2021-08-16 4:47 pm | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,200,000 | $12.5 | $40,000,000 | 841,087 (Indirect) | View |
| 2021-08-12 Purchase | 2021-08-16 4:21 pm | Eliem Therapeutics Inc. | ELYM | AI ETI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 800,000 | $12.5 | $10,000,000 | 5,009,400 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-18 Option Award | 2023-05-22 5:22 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 10,000 | $0 | 10,000 (Indirect) | View |
| 2023-05-18 Option Award | 2023-05-22 5:13 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | Tate Simon Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 5:11 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 5:08 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | Dunn Judith Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 5:05 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director | 10,000 | $0 | 188,100 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 5:02 pm | N/A 2033-05-17 | Eliem Therapeutics Inc. | ELYM | Levin Andrew David Executive Chairman | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2023-03-21 10:21 am | N/A 2031-04-26 | Eliem Therapeutics Inc. | ELYM | Pimblett Emily Chief Accounting Officer | 0 | $0 | 95,000 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:04 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO | 255,219 | $0.002 | 533,353 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:04 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO | 61,191 | $0.0002 | 533,353 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:04 pm | N/A 2030-02-03 | Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO | 316,410 | $0 | 533,353 (Direct) | View |
| 2022-10-31 Option Award | 2022-11-02 7:11 pm | N/A 2032-10-30 | Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO | 170,000 | $0 | 320,322 (Direct) | View |
| 2022-10-31 Option Award | 2022-11-02 7:09 pm | N/A 2032-10-30 | Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-10-31 Option Award | 2022-11-02 7:08 pm | N/A 2032-10-30 | Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-10-31 Option Award | 2022-11-02 7:06 pm | N/A 2032-10-30 | Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel | 95,000 | $0 | 95,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:17 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Tate Simon Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:15 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 10,000 | $0 | 10,000 (Indirect) | View |
| 2022-05-19 Option Award | 2022-06-01 5:14 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:12 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | PATTERSON LEONE D Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:10 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director | 10,000 | $0 | 188,100 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:07 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:02 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Dunn Judith Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:16 pm | N/A 2032-01-26 | Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:13 pm | N/A 2032-01-26 | Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:11 pm | N/A 2032-01-26 | Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:06 pm | N/A 2032-01-26 | Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel | 95,000 | $0 | 95,000 (Direct) | View |
| 2021-08-12 Conversion | 2021-08-16 4:47 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,446,573 | $0 | 841,087 (Indirect) | View |
| 2021-08-12 Conversion | 2021-08-16 4:21 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | AI ETI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 8,418,800 | $0 | 5,009,400 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:28 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 20,000 | $0 | 20,000 (Indirect) | View |
| 2021-08-09 Option Award | 2021-08-11 5:23 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:20 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:17 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | Tate Simon Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:14 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2021-08-09 9:01 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | AI ETI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 0 | $0 | 4,209,400 (Direct) | View |
Ownership | 2021-08-09 6:27 pm | N/A 2031-03-05 | Eliem Therapeutics Inc. | ELYM | Dunn Judith Director | 0 | $0 | 54,581 (Direct) | View |
Ownership | 2021-08-09 6:25 pm | N/A 2031-03-05 | Eliem Therapeutics Inc. | ELYM | PATTERSON LEONE D Director | 0 | $0 | 54,581 (Direct) | View |
Ownership | 2021-08-09 6:22 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-08-09 6:20 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director | 0 | $0 | 178,100 (Direct) | View |
Ownership | 2021-08-09 6:18 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Tate Simon Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-08-09 6:16 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 9,950,849 (Indirect) | View |
Ownership | 2021-08-09 6:16 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-08-09 6:13 pm | N/A 2031-02-25 | Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel | 0 | $0 | 198,410 (Direct) | View |
Ownership | 2021-08-09 6:11 pm | N/A 2031-02-25 | Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO | 0 | $0 | 357,138 (Direct) | View |